BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 8 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 8 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 8 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 10 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 10 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 10 hours ago Atmus Welcomes Heath Sharp to Board of Directors 12 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 12 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 8 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 8 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 8 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 10 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 10 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 10 hours ago Atmus Welcomes Heath Sharp to Board of Directors 12 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 12 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago
ADVERTISEMENT

Affimed N.V. (AFMD) Q3 2020 Earnings Call Transcript

Affimed N.V.  (NASDAQ: AFMD) Q3 2020 earnings call dated Nov. 10, 2020 Corporate Participants: Alexander Fudukidis — Head of Investor Relations Adi Hoess — Chief Executive Officer Andreas Harstrick — Chief…

Market News

Affimed (AFMD): Q3 2019 Earnings Snapshot

— Affimed NV (NASDAQ: AFMD) reported Q3 2019 loss of EUR0.17 per share, vs. EUR0.19 reported last year. — Revenues were EUR2.1 million, vs. EUR0.3…